Home > Healthcare > Biotechnology > Biopharma > Live cell encapsulation Market

Live cell encapsulation Market Share

Report ID: GMI5684
Published Date: May 2023
Report Format: PDF

Download Free Sample

Live Cell Encapsulation Market Share

Some of the major market players operating in the live cell encapsulation market are:

Austrianova
Merck KGaA
Sphere Fluidics Limited
Blacktrace Holdings Ltd
BIO INX
Isogen

These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for live cell encapsulation was USD 251 million in 2022 and will reach USD 370 million by 2032 due to higher application in the development of therapeutics for various chronic ailments, such as cancer, diabetes, and autoimmune diseases.

Live cell encapsulation industry share from the drug delivery application segment will showcase 4.3% CAGR from 2023-2032 owing to increasing manufacturing of tablets, capsules, and parenteral dosage forms for efficient drug delivery.

U.S. market size for Live cell encapsulation reached USD 79.4 million in 2022 on account of the increasing prevalence of diabetes.

Austrianova, Merck KGaA, Sphere Fluidics Limited, Blacktrace Holdings Ltd., BIO INX, and Isogen, are some of the prominent live cell encapsulation firms.